Standout Papers

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid ... 2001 2026 2009 2017 3.7k
  1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia (2001)
    Brian Druker, Moshe Talpaz et al. New England Journal of Medicine
  2. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome (2001)
    Brian Druker, Charles L. Sawyers et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 23 from Science/Nature 156 standout
Sub-graph 1 of 17

Citing Papers

Small molecules, big impact: 20 years of targeted therapy in oncology
2020 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
22 intermediate papers

Works of J. Ford being referenced

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
J. Ford 4775 2226 3280 57 8.4k
Jürgen Thiele 6070 823 4775 71 8.6k
Junia V. Melo 7131 1734 5468 119 10.0k
Bayard D. Clarkson 2948 2150 1752 154 8.1k
Hagop Kantarjian 4871 1588 3143 128 7.3k
Bruno Varet 4025 1435 2584 144 7.4k
Nicole Casadevall 5421 1290 4419 166 10.3k
Gérald Marit 5384 2936 2105 190 8.0k
Marilyn L. Slovak 6670 3922 2194 151 11.3k
Jerry A. Katzmann 5249 2572 2507 171 10.3k
Miloslav Beran 5188 1758 3342 106 8.4k

All Works

Loading papers...

Rankless by CCL
2026